New set of 73 Real World Evidence examples illustrate how RWD can support rigorous validation of novel device software functions across multiple disease areas.
Currently there is a great deal of variability in risk-mitigating AI development and deployment practices. The documentation of unwarranted variability in clinical practices led to the evidence-based ...
The US Food and Drug Administration (FDA) is offering a detailed look at how real-world evidence sources – from registries to claims data – can be used to support marketing applications for medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results